Redmile Group »

Dbv Technologies Sa shares owned by Redmile Group

Quarter-by-quarter ownership of Dbv Technologies Sa (DBVT) shares owned by Redmile Group from 13F filings

Historical chart of Redmile Group investment in Dbv Technologies Sa

Tip: Access up to 7 years of quarterly data

All positions including Dbv Technologies Sa held by Redmile Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dbv Technologies Sa by Redmile Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $11M 550k 19.17

More positions owned by Redmile Group

Scholar Rock Hldg Corp (SRRK)
Krystal Biotech (KRYS)
Nurix Therapeutics (NRIX)
Stoke Therapeutics (STOK)
Immunome (IMNM)
Regenxbio Inc equity us cm (RGNX)
Adc Therapeutics Sa SHS (ADCT)
Cogent Biosciences (COGT)
Annexon (ANNX)
Beam Therapeutics (BEAM)
Neurogene (NGNE)
Rapt Therapeutics Com New (RAPT)
Absci Corp (ABSI)
Nuvation Bio Com Cl A (NUVB)
Ideaya Biosciences (IDYA)

View all positions for Redmile Group

Top funds holding Dbv Technologies Sa

Artisan Partners Limited Partnership
Vivo Capital
Siren
Baker Bros. Advisors
MPM Oncology Impact Management
Millennium Management
Yiheng Capital
Octagon Capital Advisors
Redmile Group
Ikarian Capital
Schonfeld Strategic Advisors
Patient Square Capital
Vestal Point Capital
UBS Group
Balyasny Asset Management

View all funds holding Dbv Technologies Sa